RBM42 inhibitors are a class of chemical compounds that specifically target and inhibit the function of RBM42, an RNA-binding motif protein involved in post-transcriptional gene regulation. RBM42 plays a crucial role in RNA metabolism, particularly in regulating alternative splicing, mRNA stability, and RNA transport. Like other members of the RNA-binding motif (RBM) family, RBM42 contains RNA recognition motifs (RRMs) that allow it to bind to specific RNA sequences, thereby influencing how RNA is processed and ultimately translated into proteins. This protein is involved in modulating the inclusion or exclusion of exons during splicing, which generates different mRNA isoforms from a single gene, contributing to protein diversity within cells. Inhibitors of RBM42 function by binding to critical regions of the protein, such as its RNA-binding domain, thereby disrupting its interaction with RNA and hindering its regulatory functions in RNA processing.
The inhibition of RBM42 can lead to significant changes in gene expression, particularly in the alternative splicing patterns of key mRNAs. By preventing RBM42 from binding to RNA, these inhibitors disrupt the normal processing of pre-mRNA, which can affect the production of specific protein isoforms crucial for various cellular functions. Researchers use RBM42 inhibitors to investigate the specific role of this protein in splicing regulation and how it contributes to the broader networks of RNA metabolism. These inhibitors are also valuable tools for understanding the mechanisms that control post-transcriptional gene regulation, shedding light on how RNA-binding proteins like RBM42 influence cellular differentiation, growth, and function. Additionally, the study of RBM42 inhibitors provides insights into the broader landscape of RNA-protein interactions and their impact on gene expression. By examining the effects of inhibiting RBM42, researchers can better understand the molecular processes that govern RNA processing and how alterations in these processes contribute to various biological outcomes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Inhibits RNA synthesis by intercalating DNA; thus can suppress the RNA substrates that RBM42 interacts with. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Inhibits BRD4, a protein that may co-localize with RBM42; leads to reduced RNA-binding affinity of RBM42. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A DNA methyltransferase inhibitor that can modulate gene expression and influence RBM42 mRNA levels. | ||||||
SGC-CBP30 | 1613695-14-9 | sc-473871 sc-473871A | 5 mg 10 mg | $178.00 $338.00 | ||
Inhibits CBP/p300 bromodomains, affecting chromatin structure and potentially altering RBM42 RNA binding. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA polymerase II, reducing mRNA transcription rates and thereby affecting RBM42 activity. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II; can reduce the availability of RNA substrates that RBM42 would interact with. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $275.00 | 5 | |
Causes RNA cleavage; alters the availability and quality of RNA substrates for RBM42. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
DNA methyltransferase inhibitor that can modulate RBM42 gene expression. | ||||||
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $245.00 | ||
Inhibits RNA Pol I, thereby affecting rRNA synthesis, which may influence RBM42 activity. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
P300/CBP inhibitor that may indirectly alter RBM42’s RNA binding affinity by affecting chromatin structure. | ||||||